KRT18 and neoplasm: Our on-going clinical studies performed on gastric, pancreatic, lung and cholangiocellular carcinoma patients indicated that CTCs with visible strong CK18 expression revealed by i•FISH® seemed to correlate to patients’ rapid tumor progression and high mortality even at TNM early stage.